结构性切断IL-1R2增强了HeLa细胞的抗炎活性
Isao Kato1,2, Yoshiyuki Hagiwara2, Masatake Asano3,4
1Division of Applied Oral Sciences, Nihon University Graduate School of Dentistry.
Cell structure and function
|December 14, 2025
概括
介素-1受体2型 (IL-1R2) 的结构变化增强了它的诱功能. 修改后的IL-1R2变种显示出改善的抑制炎症信号,提供了新的治疗见解.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 介素-1受体2型 (IL-1R2) 作为诱受体,结合IL-1α以抑制炎症信号传递.
- IL-1R2的膜结合和可溶性形式都有助于抗炎作用,但功能因细胞环境和受体结构而异.
研究的目的:
- 研究IL-1R2的结构修改,特别是缺少跨膜或跨膜和细胞质域的删除突变,如何影响它的诱受体功能.
- 为了比较野生类型 (WT) IL-1R2与这些突变体在抑制HeLa细胞中IL-1-诱导的炎症反应中的疗效.
主要方法:
- 产生IL-1R2删除突变体 (ΔTM和ΔTMCP).
- 评估受体表达,IL-1α结合和IL-1β诱导的IL-8产生,使用西式涂抹,免疫沉和ELISA.
- 在HeLa细胞中对突变和WT IL-1R2功能的比较.
主要成果:
- 删除IL-1R2突变体 (ΔTM, ΔTMCP) 的分泌效率高于WT IL-1R2.2.
- 虽然WT IL-1R2表现出较弱的细胞内IL-1α结合,但突变物具有最小的结合,表明细胞外活性增强.
- 这两种突变都比WT IL-1R2更有效地抑制了IL-1β诱导的IL-8产生,这表明诱活性增强.
结论:
- IL-1R2的结构修改显著影响其诱受体功能.
- 与WT IL-1R2相比,IL-1R2删除突变体表现出增强的细胞外诱活性和优越的IL-1信号抑制.
- 这些发现突显了可溶性IL-1R2变体在非免疫细胞中的抗炎潜力.
相关概念视频
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Receptor Downregulation in MVBs
2.7K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.7K
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
The JAK-STAT Signaling Pathway
11.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
11.8K


